Display Options:
Total: 1404
Antibody
Investigational
Unknown
Unknown
Hematologic Diseases; Multiple Myeloma; Neoplasms
G-protein coupled receptor family C group 5 member D binding agent
Antibody
Investigational
Unknown
Unknown
Ovarian Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
Antibody
Unknown
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Delta-like protein 4 binding agent
Antibody
Investigational
Unknown
Unknown
Hodgkin Disease; Lymphoma, Non-Hodgkin
Interleukin-2 receptor alpha chain binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Nasopharyngeal Neoplasms; Small Cell Lung Carcinoma
Epidermal growth factor receptor erbB1 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Inducible T-cell costimulator inhibitor
Antibody
Investigational
Unknown
Unknown
Asthma; Autoimmune Diseases; Dermatomyositis; Inflammation; Respiratory Distress Syndrome; Graft vs Host Disease; Severe Acute Respiratory Syndrome
T-cell differentiation antigen CD6 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Fibronectin binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor binding agent
Antibody
Investigational
Unknown
Unknown
Central Nervous System Neoplasms
Elongation factor 2 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Envelope polyprotein GP160 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
Antibody
Unknown
Unknown
Unknown
Multiple Myeloma; Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Proheparin-binding EGF-like growth factor inhibitor
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Lymphoma
CD22 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Interleukin 17A inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms
DNA disrupting agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
B-lymphocyte antigen CD19 binding agent
Antibody
Investigational
Unknown
Unknown
Hypercholesterolemia; Neoplasms; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type II
Subtilisin/kexin type 9 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Unknown
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown